| Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels: New Roles for Soluble RAGE. | |
| | |
MedLine Citation:
|
PMID: 20685687 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
AIMS: Knowledge of the role of advanced glycation end products (AGE), their receptor (RAGE), and the receptor's soluble form (sRAGE), in heart failure (HF) is very limited. We evaluated the clinical role of the AGE-RAGE system in HF and in particular any association it might have with ischaemic aetiology. METHODS AND RESULTS: We measured fluorescent AGE, glycated albumin and sRAGE in 103 patients with chronic HF. We showed that sRAGE but not AGE was related to ischaemic aetiology (1638.3 ± 207.4 ischaemic vs. 1065.1 ± 94.2 pg/mL non-ischaemic group; P =0.016) independent of age, sex, diabetes, renal function, clinical severity, or other variables (OR: 1.091; 95% CI (confidence interval): 1.032-1.153; P =0.007). Moreover, sRAGE was directly associated with extent of coronary disease (OR for three vessel disease compared with non-coronary lesions: 1.186; 95% CI: 1.065-1.322; P =0.002). We also found a correlation between sRAGE and severity of HF, which increased with New York Heart Association (NYHA) class (741.9 ± 88.9 pg/mL in class 1, 1195.9 ± 113.2 pg/mL in class II, and 1724.8 ± 245.7 pg/mL in class III (P < 0.05)) and brain natriuretic peptide (BNP) levels (667.4 ± 68.0 vs. 1344.5 ± 126.0 pg/mL for BNP < and ≥400 pg/mL, respectively). CONCLUSION: sRAGE is an indicator of chronic heart failure severity and an independent marker of coronary artery disease and its severity in patients with CHF. |
| | |
Authors:
|
Sergio Raposeiras-Roubín; Bruno K Rodiño-Janeiro; Lilian Grigorian-Shamagian; María Moure-González; Ana Seoane-Blanco; Alfonso Varela-Román; Ezequiel Alvarez; José R González-Juanatey |
Related Documents
:
|
2948057 - Plasma levels of atrial natriuretic peptide (anp) in volume expanded patients: response... 14746557 - Qrs prolongation on surface ecg and brain natriuretic peptide as indicators of left ven... 15660737 - Nt-probnp in normoalbuminuric patients with type 2 diabetes mellitus. 12709407 - Increased cardiac bnp expression associated with myocardial ischemia. 20819837 - Usefulness of right ventricular myocardial strain in assessment of response to thrombol... 3820577 - Projection of death rates from ischemic heart disease in japan, 1985-2000. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-08-03 |
Journal Detail:
|
Title: European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology Volume: 12 ISSN: 1879-0844 ISO Abbreviation: Eur. J. Heart Fail. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100887595 Medline TA: Eur J Heart Fail Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 1092-100 Citation Subset: IM |
Affiliation:
|
Cardiology Department and Coronary Unit, Clinical Hospital of Santiago de Compostela, Santiago, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Length of delay in seeking medical care by patients with heart failure symptoms and the role of symp...
Next Document: Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality...